IGF1 anticorps (Isoform 4)
Aperçu rapide pour IGF1 anticorps (Isoform 4) (ABIN4889287)
Antigène
Voir toutes IGF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Isoform 4
-
Specificité
- Reacts with human Isoform 4 of Insulin-like growth factor I
-
Purification
- Purified (protein A)
-
Immunogène
- Synthetic peptide derived from Isoform 4 of Insulin-like growth factor I
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- WB : 1/500 to 1/5 000 - IHC : 1/100 to 1/2 000 -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Concentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 24 months
-
-
- IGF1 (Insulin-Like Growth Factor 1 (IGF1))
-
Autre désignation
- Insulin-Like Growth Factor I (IGF-I)
-
Sujet
- Insulin-like growth factor I (IGF-I)is involved in DNA replication, signal transduction, cellular componant mobility...
-
Pathways
- Signalisation RTK, Intracellular Steroid Hormone Receptor Signaling Pathway, Peptide Hormone Metabolism, Hormone Activity, Regulation of Intracellular Steroid Hormone Receptor Signaling, Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Stem Cell Maintenance, Glycosaminoglycan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Autophagy, Smooth Muscle Cell Migration, Activated T Cell Proliferation, Positive Regulation of fat Cell Differentiation
Antigène
-